Academic rigor, journalistic flair
Professor, Monash University
Chris Langmead is Professor, Deputy Director, and Better Medicines Theme Leader of the Neuromedicines Discovery Centre at the Monash Institute of Pharmaceutical Sciences (MIPS), a collaborative venture targeting new medicines development for poorly-treated mental health disorders. He is also the co-founder and CEO of Phrenix Therapeutics, which is developing next-generation therapeutics for schizophrenia.
Experience
-
2012–2023Professor & Deputy Director, Monash University
-
2009–2012Head of Pharmacology, Heptares Therapeutics Ltd.
-
1998–2009Team Leader, GSK
- Parkville, VIC 3052, AUSTRALIA
- Website
- @chrislangmead
- Article Feed
- ORCID
- Joined
